The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Halstead Regulatory News (JHD)

Share Price Information for James Halstead (JHD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 199.50
Bid: 200.00
Ask: 203.00
Change: -2.50 (-1.24%)
Spread: 3.00 (1.50%)
Open: 200.00
High: 204.00
Low: 198.00
Prev. Close: 202.00
JHD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

1 Aug 2023 07:00

RNS Number : 7384H
James Halstead PLC
01 August 2023
 

 

1 August 2023

 

 

JAMES HALSTEAD PLC (the "Company")

Trading Update

James Halstead plc, the commercial flooring manufacturer and international distributor, is providing the following trading update ahead of its results for the year ended 30 June 2023.

 

The Company's market expectations for the full year remain unchanged.

 

2023 was a year of contrast, with the earlier months of the financial year having faced escalating energy costs, severe difficulties as a result of the lack of timely availability of international shipping and increased transportation costs. However, the latter months of the year were much more positive with the easing of electricity costs and a great improvement in shipping and transportation costs.

 

Sales demand has, on the whole, proved positive with the UK, the Americas, Australia, New Zealand and Malaysia all reporting increased demand, although Central Europe sales were lower than last year. Also positive for the year, gross margins improved for the reasons already noted and were helped by a swing in the mix of sales to pure commercial ranges as opposed to light commercial/heavy domestic. The core focus of our flooring ranges in healthcare, education and retail infrastructure, rather than private residential, remains a key benefit to our business model. 

 

In March 2023, the UK finalised an agreement to join the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP). The agreement sees the UK joining the CPTPP, whose membership consists of Australia, Canada, Japan, Mexico, New Zealand, Singapore, Brunei, Chile, Malaysia, Peru and Vietnam. Following the agreement, the UK government estimates that over 99 per cent of UK exports to the bloc will be eligible for zero tariffs. James Halstead exports various product lines to 10 of the 11 CPTPP member countries (the exception being Brunei), representing an estimated c.8% of its global revenue, where import tariffs range between 5% - 20%. This is good news for the competiveness of our products in these markets.

 

Stock levels that were strategically raised last year are now at much lower levels and our cash balances are robust and ahead of comparatives at 30 June 2022 and 31 December 2022, even though record levels of dividend and taxation have been paid out during the year.

 

The Company expects to announce its results for the year ended 30 June 2023 on 2 October 2023.

 

 

 

 

 

Enquiries:

 

 

 

James Halstead plc

Tel: 0161 767 2500

 

Mark Halstead, Chief Executive

 

Gordon Oliver, Finance Director

 

 

 

Hudson Sandler

Tel: 020 7796 4133

 

Nick Lyon / Nick Moore

 

 

Panmure Gordon (Nomad and Joint Broker)

Tel: 020 7886 2500

 

Dominic Morley

 

 

WH Ireland (Joint Broker)

Ben Thorne / Chris Hardie

 

Tel: 020 7220 1666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKDBBCBKKPON
Date   Source Headline
13th Jan 20113:30 pmRNSIssue of Equity and Total Voting Rights
12th Jan 20119:30 amRNSBonus Issue
4th Jan 20119:45 amRNSTotal Voting Rights
4th Jan 20119:10 amRNSBlocklisting Interim Review
21st Dec 20103:45 pmRNSDirector/PDMR Shareholding
3rd Dec 20107:00 amRNSAnnual General Meeting
1st Nov 20107:00 amRNSTotal Voting Rights
25th Oct 20109:15 amRNSAnnual Report and Accounts
25th Oct 20109:15 amRNSAnnual Report and Accounts
30th Sep 20107:00 amRNSPreliminary Results
23rd Jul 20107:00 amRNSPre-Close Trading Update
1st Jul 20107:00 amRNSBlocklisting Interim Review
6th Apr 201012:00 pmRNSTotal Voting Rights
31st Mar 20104:17 pmRNSDirector/PDMR Shareholding
31st Mar 20107:00 amRNSInterim Results
1st Mar 20107:00 amRNSTotal Voting Rights
25th Jan 20107:00 amRNSPre-close Trading Statement
4th Jan 20107:00 amRNSBlocklisting Interim Review
31st Dec 20097:00 amRNSTotal Voting Rights
18th Dec 20094:00 pmRNSAnnual Report and Accounts
14th Dec 200911:30 amRNSDirector's shareholding
10th Dec 20093:00 pmRNSDirector's shareholding
7th Dec 20091:50 pmRNSDirector's shareholding
4th Dec 20091:00 pmRNSDividend Declaration
4th Dec 20097:00 amRNSAGM Statement
12th Oct 200912:00 pmRNSDirector/PDMR Shareholding
29th Sep 20097:00 amRNSPreliminary Results
17th Sep 200911:37 amRNSNotice of Preliminary Results
29th Jul 20097:00 amRNSPre-Close Trading Update
1st Jul 200912:30 pmRNSBlocklisting Interim Review
30th Mar 20094:45 pmRNSDividend Declaration - Correction
30th Mar 20097:00 amRNSInterim Results
17th Mar 20093:12 pmRNSNotice of Results
26th Feb 20098:00 amRNSBlocklisting Interim Review
28th Jan 20097:00 amRNSPre-close Trading Statement
22nd Dec 200812:30 pmRNSAnnual Report and Accounts
10th Dec 20087:00 amRNSAGM Statement
8th Oct 200812:00 pmRNSDirector/PDMR Shareholding
6th Oct 20085:00 pmRNSDirector/PDMR Shareholding
30th Sep 20085:08 pmRNSDirectors' Dealings
30th Sep 20087:00 amRNSFinal Results
24th Sep 20087:00 amRNSExecutive Board Appointment
19th Sep 20084:50 pmRNSSecond Price Monitoring Extn
19th Sep 20084:35 pmRNSPrice Monitoring Extension
16th Sep 200810:00 amRNSNotice of Results
4th Sep 20087:00 amRNSNotice of Results
31st Jul 20087:00 amRNSTotal Voting Rights
3rd Jul 20081:00 pmRNSBlocklisting Interim Review
1st Jul 20087:00 amRNSTrading Statement
11th Jun 20081:00 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.